VIR FY 2023 Earnings — Vir Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

VIRVir Biotechnology, Inc.

$1B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$86M-94.7% YoY

Gross Profit

-$487M-564.7% margin

Operating Income

-$684M-794.0% margin

Net Income

-$615M-713.7% margin

EPS (Diluted)

$-4.59

Cash Flow

Operating Cash Flow

-$779M

Free Cash Flow

-$800M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1.9B

Total Liabilities

$329M

Stockholders' Equity

$1.6B

Cash & Equivalents

$242M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$86M	$1.6B	-94.7%
Gross Profit	-$487M	$995M	-148.9%
Operating Income	-$684M	$833M	-182.1%
Net Income	-$615M	$516M	-219.2%